For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts

Blog
The current state of pharmaceutical tariffs
Background Amid the Trump trade upheaval, pharmaceutical products receive different treatment than many other US imports. Pharmaceuticals are treated differently for reasons such as their…

DC Journal
Point: Medicaid Work Requirements Are a Common-Sense Reform
Medicaid is the government program that is supposed to help the poor afford health care. Its cost to taxpayers has skyrocketed in the last few…

Blog
Congress considers micromanaging PBM finances
With the first reconciliation bill behind it, Congress is now looking to reform other aspects of the health care system. Pharmacy Benefit Manager (PBM)…
Search Posts
Op-Eds
The Brundtland Legacy
The five-year tenure of Gro Harlem Brundtland as head of the World Health Organisation (WHO) has just come to an end. She leaves behind…
Op-Eds
Los Beneficios de la Biotecnologa
Click on pdf link above to obtain full article…
Op-Eds
The Benefits of Biotech
Click pdf link above for full text of article Ever since the publication of Rachel Carson’s…
USA Today
Republican Senator, Auto-Safety Advocate Form Unlikely Alliance
Op-Eds
Misfires in Biotech Trenches
Agricultural biotechnology suddenly is headline news—the focus of a vitriolic trans-Atlantic trade squabble, and even the subject of pointed public comments by President…
News Release
Drug Re-Importation Bill: Cheaper Drugs Today, But Fewer Medicines Tomorrow
Contact for Interviews: Richard Morrison, 202.331.2273 or Jody Clarke, 202.331.2252 Washington, D.C., July 25, 2003—The vote by the U.S. House to allow the re-importation of…